z-logo
open-access-imgOpen Access
Percutaneous Epidural Adhesiolysis Using Inflatable Balloon Catheter and Balloon-less Catheter in Central Lumbar Spinal Stenosis with Neurogenic Claudication: A Randomized Controlled Trial
Author(s) -
Seong-Soo Choi
Publication year - 2018
Publication title -
pain physician
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.31
H-Index - 99
eISSN - 2150-1149
pISSN - 1533-3159
DOI - 10.36076/ppj.2018.6.593
Subject(s) - medicine , oswestry disability index , balloon , radicular pain , surgery , inflatable , catheter , randomized controlled trial , percutaneous , lumbar , lumbar spinal stenosis , interventional pain management , neurogenic claudication , epidural steroid injection , low back pain , anesthesia , mechanical engineering , alternative medicine , pathology , engineering , pain management
Background: When conventional interventional procedures fail, percutaneous epiduraladhesiolysis (PEA), which has moderate evidence for successful treatment of lumbar spinal stenosis(LSS), has been recommended over surgical treatments. In a previous study, we demonstrated theefficacy of a newly developed inflatable balloon catheter for overcoming the access limitations ofpre-existing catheters for patients with severe stenosis or adhesions.Objectives: This study compared the treatment response of combined PEA with balloondecompression and PEA only in patients with central LSS over 6 months of follow-up.Study Design: This study used a randomized, single-blinded, active-controlled trial design.Setting: This study took place in a single-center, academic, outpatient interventional painmanagement clinic.Methods: This randomized controlled study included 60 patients with refractory central LSS whosuffered from chronic lower back pain and/or lumbar radicular pain. Patients failed to maintainimprovement for > 1 month with epidural steroid injection or PEA using a balloon-less catheter.Patients were randomly assigned to one of 2 interventions: balloon-less (n = 30) and inflatableballoon catheter (n = 30). The Numeric Rating Scale (NRS-11), Oswestry Disability Index (ODI),Global Perceived Effect of Satisfaction (GPES), and Medication Quantification Scale III were eachmeasured at 1, 3, and 6 months after PEA.Results: There was a significant difference between groups in NRS-11 reduction ≥ 50% (or 4points), ODI reduction ≥ 30% (or 10 points), GPES ≥ 6 and ≥ 4 points at 6 months, and NRS11 reduction ≥ 50% (or 4 points) at 3 months after PEA (P < .03). The proportion of successfulresponders was higher in the balloon group than in the balloon-less group throughout the totalfollow-up period. Furthermore, there was a statistically significant difference between groups at 6months after PEA (P = .035).Limitations: The results may vary according to the definition of successful response. Follow-uploss in the present study seemed to be high.Conclusion: PEA using the inflatable balloon catheter leads to significant pain reduction andfunctional improvement compared to PEA using the balloon-less catheter in patients with centralLSS.The study protocol was approved by our institutional review board (2012-0235), and writteninformed consent was obtained from all patients. The trial was registered with the Clinical ResearchInformation Service (KCT 0002093).Key words: Balloon decompression, central, chronic pain, epidural adhesiolysis, lumbar,percutaneous, radiculopathy, spinal stenosis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here